Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/9093707

Download in:

View as

General Info

PMID
9093707